# Victor Decrion

> Victor Decrion is a secondary market investor at Lauxera Capital Partners backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lauxera Capital Partners](https://shizune.co/investors/profile/lauxera-capital-partners)
- Location: Paris, France
- Total investments: 1
- Last investment: Jul 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/victor-decrion-4055491

Victor Decrion is a secondary market investor at Lauxera Capital Partners in Paris focused on Biotechnology. Victor Decrion

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GenePlanet | GenePlanet is a European company active in the field of biotechnology, specializing in genetic testing and research. They specialize in preventive genetic tests that are intended for the end user, but they also offer clinical genetic tests which help doctors with their therapeutic procedures. Their tests adhere to the highest standards of qualityand are based on the latest scientific discoveries. They provide people with information which can help them adjust their lifestyle accordingly and take measures that will provide additional protection from health risks due to genetic predispositions. |  | Secondary Market | Jul 30, 2026 |  |

1 of 1 investments shown.

## About Lauxera Capital Partners

VC Fund · Paris, France

Lauxera Capital Partners is an independent, international, healthcare-focused asset management company. Our growth equity investments focus primarily on commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with experienceacross international markets, we empower European healthtech entrepreneurs to deliver the growth promised by their innovations.Lauxera was created in 2020 and has offices in Paris and San Francisco.

3 contacts available at Lauxera Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Slack | Co-Founder | https://shizune.co/investors/profile/alex-slack |
| Samuel Levy | Founding Partner | https://shizune.co/investors/profile/dr-samuel-levy |
| Victor Decrion | Managing Partner | https://shizune.co/investors/profile/victor-decrion-1ffa |

## Similar investors

### Similar stage
- [Salica](https://shizune.co/investors/profile/hambroperksltd) — VC Fund
- [Growth Engine](https://shizune.co/investors/profile/growth-engine-2cd7) — VC Fund
- [Marco Valta](https://shizune.co/investors/profile/marco-valta) — Angel Investor

## FAQ

### What does Victor Decrion invest in?

Victor Decrion invests primarily in Biotechnology startups, most often at Secondary Market stage. Most of the 1 investments tracked by Shizune back companies in Slovenia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Victor Decrion last invest?

The most recent investment recorded for Victor Decrion closed in Jul 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co